Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

HCWB

HCW Biologics Inc

Feb 12 • 12:27PM ET

0.8824

-0.1078 -10.89 %

Healthcare • Biotechnology • USA • NASD

Peers: LGND AUPH BYSI IVA FATE ARDX GERN CRBP TVRD CBIO

| Held by: VXF

Index	-	P/E	-	EPS (ttm)	-13.96	Insider Own	24.24%	Shs Outstand	2.62M	Perf Week	-10.87%
Market Cap	2.90M	Forward P/E	-	EPS next Y	-1.15	Insider Trans	0.00%	Shs Float	2.48M	Perf Month	-26.47%
Enterprise Value	9.30M	PEG	-	EPS next Q	-0.84	Inst Own	4.51%	Short Float	2.18%	Perf Quarter	-68.82%
Income	-22.21M	P/S	6.90	EPS this Y	83.02%	Inst Trans	-11.54%	Short Ratio	0.58	Perf Half Y	-80.35%
Sales	0.42M	P/B	-	EPS next Y	78.01%	ROA	-85.40%	Short Interest	0.05M	Perf YTD	-9.09%
Book/sh	-0.80	P/C	2.63	EPS next 5Y	68.64%	ROE	-27725.80%	52W High	17.80 -95.04%	Perf Year	-94.49%
Cash/sh	0.34	P/FCF	-	EPS past 3/5Y	-29.11% -29.55%	ROIC	-	52W Low	0.95 -7.43%	Perf 3Y	-98.84%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-351.39%	Volatility	8.27% 10.79%	Perf 5Y	-
Dividend TTM	-	EV/Sales	22.13	EPS Y/Y TTM	65.26%	Oper. Margin	-3157.10%	ATR (14)	0.13	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.06	Sales Y/Y TTM	-87.93%	Profit Margin	-5261.78%	RSI (14)	29.23	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.06	EPS Q/Q	51.17%	SMA20	-23.96%	Beta	0.72	Target Price	8.00
Payout	-	Debt/Eq	-	Sales Q/Q	-96.34%	SMA50	-36.60%	Rel Volume	1.54	Prev Close	0.99
Employees	36	LT Debt/Eq	-	Earnings	Nov 14 AMC	SMA200	-77.39%	Avg Volume	93.49K	Price	0.88
IPO	Jul 20, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	-361.39% -98.78%	Trades		Volume	69,474	Change	-10.89%

Nov-19-25 08:30AM	HCW Biologics Enters into $4.0 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -17.01%
Nov-18-25 07:25AM	HCW Biologics Announces Initiation of First-In-Human Clinical Trial to Evaluate HCW9302 in an Autoimmune Disease (GlobeNewswire) -21.24%
Nov-14-25 04:44PM	HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results (GlobeNewswire) +20.48%
Nov-10-25 07:00AM	HCW Biologics Shares the Latest Data for its Second-Generation Immune Checkpoint Inhibitor Presented at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (GlobeNewswire)
Nov-07-25 07:00AM	HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting (GlobeNewswire) -9.04%
09:00AM	Loading…
Oct-22-25 09:00AM	HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor "What This Means" Segment (GlobeNewswire)
Oct-16-25 09:25AM	HCW Biologics to Participate in the 2025 Maxim Growth Summit (GlobeNewswire) -7.37%
09:15AM	HCW Biologics' Scientists to Present Three Posters During the 40th Annual Meeting of the Society for Immunotherapy of Cancer (GlobeNewswire)
Sep-30-25 08:45AM	HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor "What This Means" Segment About its Proprietary T-Cell Engager Program (GlobeNewswire)
Sep-18-25 09:15AM	HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing (GlobeNewswire) +5.34%
09:10AM	Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics (PR Newswire)
Sep-16-25 08:00AM	HCW Biologics Designates One of Its Proprietary TRBC-Pembrolizumab-Based Immune Checkpoint Inhibitors as its Franchise Immunotherapeutic for Internal Clinical Development (GlobeNewswire) -15.31%
Sep-09-25 08:00AM	HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Generation T-Cell Engager Program (GlobeNewswire) -6.82%
Aug-25-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +60.82%
08:00AM	HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion Dollar Market (GlobeNewswire)
02:44PM	Loading…
Aug-18-25 02:44PM	HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results (GlobeNewswire)
Jun-27-25 07:45AM	HCW Biologics to Showcase Important Updates on IND-Enabling Studies and Preclinical Success of Its Novel Multi-Specific T-Cell Engagers Against Solid Tumors (GlobeNewswire) +6.64%
Jun-26-25 07:55AM	HCW Biologics Regains Compliance with Nasdaq Capital Market Requirements (GlobeNewswire) -5.17%
Jun-04-25 08:20AM	HCW Biologics Completes Deliverable and Solidifies License Agreement with WY Biotech (GlobeNewswire) -8.36%
May-15-25 06:14PM	HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results (GlobeNewswire) -6.92% +9.15%
May-13-25 08:01PM	HCW Biologics Announces Pricing of $5.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules (GlobeNewswire) +92.90% -12.34%
08:30AM	HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization (GlobeNewswire)
Apr-01-25 04:35PM	HCW Biologics Announces 1-for-40 Reverse Stock Split (GlobeNewswire)
Mar-28-25 03:30PM	HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results (GlobeNewswire)
Mar-06-25 06:55AM	HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements (GlobeNewswire)
Feb-03-25 07:15AM	HCW Biologics Granted FDA Clearance to Evaluate One of the Company's Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial (GlobeNewswire) +128.58%
Jan-15-25 07:00AM	HCW Biologics' Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025 (GlobeNewswire)
Dec-23-24 08:10AM	HCW Biologics Inc. Received NASDAQ Staff Determination Letter (GlobeNewswire) -11.18%
Nov-20-24 01:55AM	HCW Biologics prices $6.9M registered direct offering at $1.03 per share (TipRanks) -13.89%
Nov-18-24 09:27PM	HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules (GlobeNewswire) +320.91% -11.29%
10:15AM	Loading…
10:15AM	Why Is Penny Stock HCW Biologics Surging On Monday? (Benzinga)
07:00AM	HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate (GlobeNewswire)
Nov-14-24 04:40PM	HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights (GlobeNewswire)
Aug-23-24 04:30PM	HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction (GlobeNewswire) +11.64% -11.21%
Aug-14-24 04:35PM	HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights (GlobeNewswire) -13.62%
May-15-24 09:53PM	HCWB Stock Earnings: HCW Biologics Reported Results for Q1 2024 (InvestorPlace) -5.17%
04:39PM	HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights (GlobeNewswire)
Apr-01-24 10:53PM	HCWB Stock Earnings: HCW Biologics Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace) -5.71%
04:10PM	HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights (GlobeNewswire)
Nov-14-23 07:00AM	HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights (GlobeNewswire) -17.73%
Nov-08-23 07:30AM	Investigator Sponsor of HCW Biologics' Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting (GlobeNewswire)
Nov-01-23 07:30AM	Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting (GlobeNewswire) -5.36%
Sep-16-23 11:00AM	Insider Buying: CFO Rebecca Byam Acquires 5,000 Shares of HCW Biologics Inc (GuruFocus.com)
Sep-14-23 01:27PM	Insider Buying: CFO Rebecca Byam Acquires 10,000 Shares of HCW Biologics Inc (GuruFocus.com) +5.45%
Sep-09-23 01:00PM	Insider Buying: CFO Rebecca Byam Acquires 10,000 Shares of HCW Biologics Inc (GuruFocus.com)
Sep-06-23 07:30AM	HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 13, 2023 (GlobeNewswire)
Aug-11-23 07:01AM	Daily Vickers Top Insider Picks for 08/11/2023 (Argus Research)
07:00AM	HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights (GlobeNewswire)
Aug-10-23 06:24AM	Daily Vickers Top Insider Picks for 08/10/2023 (Argus Research)
Aug-09-23 06:26AM	Daily Vickers Top Insider Picks for 08/09/2023 (Argus Research)
Aug-08-23 06:28AM	Daily Vickers Top Insider Picks for 08/08/2023 (Argus Research)
Aug-07-23 06:35AM	Daily Vickers Top Insider Picks for 08/07/2023 (Argus Research)
Aug-04-23 07:14AM	Daily Vickers Top Insider Picks for 08/04/2023 (Argus Research) -8.26%
Aug-03-23 07:15AM	Daily Vickers Top Insider Picks for 08/03/2023 (Argus Research)
Aug-02-23 07:52AM	Daily Vickers Top Insider Picks for 08/02/2023 (Argus Research)
Aug-01-23 06:51AM	Daily Vickers Top Insider Picks for 08/01/2023 (Argus Research)
Jul-31-23 06:44AM	Daily Vickers Top Insider Picks for 07/31/2023 (Argus Research)
Jul-28-23 07:58AM	Daily Vickers Top Insider Picks for 07/28/2023 (Argus Research)
Jul-27-23 07:10AM	Daily Vickers Top Insider Picks for 07/27/2023 (Argus Research)
Jul-26-23 01:12PM	Daily Vickers Top Insider Picks for 07/26/2023 (Argus Research)
Jul-25-23 07:16AM	Daily Vickers Top Insider Picks for 07/25/2023 (Argus Research)
Jul-24-23 07:12AM	Daily Vickers Top Insider Picks for 07/24/2023 (Argus Research)
Jul-21-23 07:23AM	Daily Vickers Top Insider Picks for 07/21/2023 (Argus Research)
Jul-20-23 06:55AM	Daily Vickers Top Insider Picks for 07/20/2023 (Argus Research)
Jul-19-23 07:10AM	Daily Vickers Top Insider Picks for 07/19/2023 (Argus Research)
Jul-18-23 06:53AM	Daily Vickers Top Insider Picks for 07/18/2023 (Argus Research)
Jul-17-23 07:10AM	Daily Vickers Top Insider Picks for 07/17/2023 (Argus Research) +5.42%
Jul-14-23 06:50AM	Daily Vickers Top Insider Picks for 07/14/2023 (Argus Research) -8.23%
Jul-13-23 07:02AM	Daily Vickers Top Insider Picks for 07/13/2023 (Argus Research) +6.45%
Jul-12-23 07:22AM	Daily Vickers Top Insider Picks for 07/12/2023 (Argus Research)
Jul-11-23 06:08AM	Daily Vickers Top Insider Picks for 07/11/2023 (Argus Research)
Jul-10-23 06:56AM	Daily Vickers Top Insider Picks for 07/10/2023 (Argus Research)
Jul-07-23 06:28AM	The past year for HCW Biologics (NASDAQ:HCWB) investors has not been profitable (Simply Wall St.)
Jul-05-23 06:46AM	Daily Vickers Top Insider Picks for 07/05/2023 (Argus Research)
Jul-03-23 06:50AM	Daily Vickers Top Insider Picks for 07/03/2023 (Argus Research)
Jun-30-23 06:52AM	Daily Vickers Top Insider Picks for 06/30/2023 (Argus Research)
Jun-29-23 06:49AM	Daily Vickers Top Insider Picks for 06/29/2023 (Argus Research)
Jun-28-23 06:58AM	Daily Vickers Top Insider Picks for 06/28/2023 (Argus Research)
Jun-27-23 06:46AM	Daily Vickers Top Insider Picks for 06/27/2023 (Argus Research)
Jun-26-23 06:41AM	Daily Vickers Top Insider Picks for 06/26/2023 (Argus Research) -5.22%
Jun-23-23 09:24AM	Daily Vickers Top Insider Picks for 06/23/2023 (Argus Research) +12.75%
Jun-22-23 07:05AM	Daily Vickers Top Insider Picks for 06/22/2023 (Argus Research)
Jun-21-23 07:05AM	Daily Vickers Top Insider Picks for 06/21/2023 (Argus Research)
Jun-20-23 06:35AM	Daily Vickers Top Insider Picks for 06/20/2023 (Argus Research)
Jun-15-23 06:38AM	Daily Vickers Top Insider Picks for 06/15/2023 (Argus Research)
Jun-14-23 07:30AM	HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders (GlobeNewswire)
06:39AM	Daily Vickers Top Insider Picks for 06/14/2023 (Argus Research)
Jun-13-23 06:37AM	Daily Vickers Top Insider Picks for 06/13/2023 (Argus Research)
Jun-12-23 06:47AM	Daily Vickers Top Insider Picks for 06/12/2023 (Argus Research)
Jun-09-23 06:34AM	Daily Vickers Top Insider Picks for 06/09/2023 (Argus Research) -6.05%
May-10-23 06:13AM	HCW Biologics First Quarter 2023 Earnings: US$0.14 loss per share (vs US$0.057 loss in 1Q 2022) (Simply Wall St.)
May-09-23 07:15AM	HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlights (GlobeNewswire)
Apr-27-23 07:40AM	HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan (GlobeNewswire)
Apr-13-23 07:15AM	HCW Biologics Poster Presentation at AACR Annual Meeting 2023 (GlobeNewswire)
Apr-03-23 08:13AM	A Novel Immunotherapeutic Approach to Treating Aging-Associated Diseases (GlobeNewswire)
Mar-28-23 04:25PM	HCW Biologics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights (GlobeNewswire) +9.77%
Feb-13-23 05:21AM	Bullish HCW Biologics Inc. (NASDAQ:HCWB) insiders filled their treasuries with US$687k worth of stock over last year (Simply Wall St.)
Jan-03-23 07:50AM	HCW Biologics (NASDAQ:HCWB) shareholders have endured a 18% loss from investing in the stock a year ago (Simply Wall St.)
Dec-08-22 07:55AM	HCW Biologics Enters CRADA with National Cancer Institute (GlobeNewswire)
Dec-07-22 07:30AM	HCW Biologics is Granted Second Fundamental Patent: U.S. Patent for Multi-Chain Chimeric Polypeptide Created with TOBI Platform (GlobeNewswire)

HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The firm considers age-related low-grade chronic inflammation as a contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. The company was founded by Hing C. Wong on April 2, 2018 and is headquartered in Miramar, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wong Hing C	Chief Executive Officer	May 16 '25	Buy	7.45	8,054	60,002	501,911	May 20 04:35 PM
Winer Gary M	Director	May 16 '25	Buy	7.45	1,342	9,998	4,075	May 20 04:35 PM
GARRETT SCOTT T	Director	May 16 '25	Buy	7.45	13,423	100,001	25,505	May 20 04:34 PM
Winer Gary M	Director	May 08 '25	Buy	26.00	2,308	60,008	2,733	May 09 05:33 PM
Wong Hing C	Chief Executive Officer	May 08 '25	Buy	26.00	92,500	2,405,000	493,857	May 09 05:32 PM
GARRETT SCOTT T	Director	May 08 '25	Buy	26.00	5,385	140,010	12,082	May 09 05:31 PM
Byam Rebecca	Chief Financial Officer	May 08 '25	Buy	26.00	8,462	220,012	43,010	May 09 05:30 PM
Flowers Lee	SVP of Business Development	May 08 '25	Buy	26.00	962	25,012	5,720	May 09 05:29 PM
Greene Rick S.	Director	May 08 '25	Buy	26.00	962	25,012	2,066	May 09 05:28 PM

Open in Screener

HOLX

Hologic, Inc

Feb 12 • 12:29PM ET

75.07

-0.01 -0.02 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: ABT BDX MDT QGEN ILMN BIO DGX A RMD

| Held by: VTI VOO VB VBR IVV SPY RSP XLV IHI IWR

Index	S&P 500	P/E	31.15	EPS (ttm)	2.41	Insider Own	1.52%	Shs Outstand	223.07M	Perf Week	0.50%
Market Cap	16.76B	Forward P/E	15.43	EPS next Y	4.87	Insider Trans	-4.12%	Shs Float	219.86M	Perf Month	0.27%
Enterprise Value	16.92B	PEG	2.15	EPS next Q	1.07	Inst Own	95.13%	Short Float	1.89%	Perf Quarter	0.64%
Income	543.90M	P/S	4.06	EPS this Y	4.47%	Inst Trans	-4.32%	Short Ratio	1.49	Perf Half Y	8.84%
Sales	4.13B	P/B	3.19	EPS next Y	9.36%	ROA	6.07%	Short Interest	4.15M	Perf YTD	0.79%
Book/sh	23.51	P/C	7.09	EPS next 5Y	7.16%	ROE	10.86%	52W High	75.36 -0.38%	Perf Year	18.17%
Cash/sh	10.59	P/FCF	17.51	EPS past 3/5Y	-21.45% -10.02%	ROIC	7.01%	52W Low	51.90 44.65%	Perf 3Y	-8.29%
Dividend Est.	-	EV/EBITDA	13.41	Sales past 3/5Y	-5.53% 1.66%	Gross Margin	55.62%	Volatility	0.27% 0.32%	Perf 5Y	-9.53%
Dividend TTM	-	EV/Sales	4.10	EPS Y/Y TTM	-23.89%	Oper. Margin	23.66%	ATR (14)	0.25	Perf 10Y	130.29%
Dividend Ex-Date	-	Quick Ratio	3.32	Sales Y/Y TTM	2.17%	Profit Margin	13.18%	RSI (14)	56.78	Recom	3.06
Dividend Gr. 3/5Y	- -	Current Ratio	4.04	EPS Q/Q	-8.44%	SMA20	0.13%	Beta	0.73	Target Price	76.57
Payout	0.00%	Debt/Eq	0.48	Sales Q/Q	2.54%	SMA50	0.24%	Rel Volume	0.42	Prev Close	75.09
Employees	7070	LT Debt/Eq	0.48	Earnings	Jan 29 AMC	SMA200	9.62%	Avg Volume	2.78M	Price	75.07
IPO	Mar 01, 1990	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.08% -2.20%	Trades		Volume	566,805	Change	-0.02%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-12-26	Downgrade	Argus	Buy → Hold
Jan-05-26	Downgrade	Evercore ISI	Outperform → In-line	$78
Nov-21-25	Downgrade	BNP Paribas Exane	Outperform → Neutral	$79
Oct-07-25	Upgrade	Evercore ISI	In-line → Outperform	$78
Aug-18-25	Upgrade	Argus	Hold → Buy	$80
Aug-06-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$87
Jul-09-25	Upgrade	Citigroup	Neutral → Buy	$80
May-27-25	Reiterated	Needham	Hold
Mar-03-25	Downgrade	Argus	Buy → Hold
Feb-06-25	Downgrade	Leerink Partners	Outperform → Market Perform	$80 → $75
Feb-03-25	Downgrade	Needham	Buy → Hold
Dec-13-24	Initiated	Wolfe Research	Peer Perform
Dec-10-24	Reiterated	Needham	Buy	$90
Dec-10-24	Initiated	Jefferies	Hold	$85
Oct-01-24	Downgrade	Citigroup	Buy → Neutral	$95 → $85
Jun-27-24	Initiated	Stephens	Overweight	$87
Apr-03-24	Upgrade	Citigroup	Neutral → Buy	$80 → $95
Jul-14-23	Upgrade	Needham	Hold → Buy	$95
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$75
Oct-13-22	Initiated	Mizuho	Buy	$75

Show Previous Ratings

Feb-10-26 08:57AM	Is Wall Street Bullish or Bearish on Hologic Stock? (Barchart)
Feb-06-26 11:45AM	Analyst Report: Hologic, Inc. (Morningstar Research)
Feb-04-26 08:15AM	Hologic Receives FDA Approval for Aptima HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio (Business Wire)
Feb-03-26 01:02PM	Robert Olstein's Strategic Moves: Exiting Hologic Inc with a -1.44% Impact (GuruFocus.com)
Feb-02-26 09:15AM	Hologic (HOLX) International Revenue Performance Explored (Zacks)
09:00AM	Loading…
09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Jan-30-26 08:28AM	HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash (Zacks)
Jan-29-26 08:42PM	Blackstone Q4 Earnings Call Highlights (MarketBeat)
06:00PM	Compared to Estimates, Hologic (HOLX) Q1 Earnings: A Look at Key Metrics (Zacks)
05:25PM	Hologic (HOLX) Misses Q1 Earnings and Revenue Estimates (Zacks)
04:19PM	Hologic: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:11PM	Hologic (NASDAQ:HOLX) Misses Q4 CY2025 Revenue Estimates (StockStory)
04:02PM	Hologic Announces Financial Results for First Quarter of Fiscal 2026 (Business Wire)
12:51PM	Will Revvity Q4 Earnings Benefit From Early Signs of Demand Recovery? (Zacks)
Jan-28-26 08:24AM	SYK's Q4 Results Likely to Reflect Procedure Growth and Capital Demand (Zacks)
06:46AM	Loading…
06:46AM	Medtech M&A took off in the second half of 2025: report (MedTech Dive)
Jan-27-26 10:10PM	Hologic (HOLX) Q4 Earnings: What To Expect (StockStory)
Jan-26-26 09:15AM	Stay Ahead of the Game With Hologic (HOLX) Q1 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Jan-23-26 04:20PM	Analysts consider potential Qiagen deal amid reported strategic review (Investing.com)
08:48AM	Danaher Gears Up to Post Q4 Earnings: What Lies Ahead for the Stock? (Zacks)
Jan-22-26 10:00AM	Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
08:50AM	Hologic Q1 Earnings Preview: How Should You Play the Stock Now? (Zacks)
Jan-21-26 12:10PM	Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:50AM	Here's Why Hologic (HOLX) is a Strong Momentum Stock (Zacks)
08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
07:51AM	Will GYN Surgical Power Hologic's Growth in the Upcoming Q1 Earnings? (Zacks)
Jan-20-26 11:34PM	Analyst Report: Hologic, Inc. (Morningstar Research)
Jan-19-26 06:02PM	Hologic, Inc. (HOLX): A Bear Case Theory (Insider Monkey)
07:52AM	HOLX vs. SYK: Which Medical Device Leader Is a Solid Bet Now? (Zacks)
11:56AM	Loading…
Jan-16-26 11:56AM	Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic (PR Newswire)
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
07:18AM	Hologic Leads Campaign to Emphasize Routine Cervical Cancer Screening (Zacks)
Jan-15-26 11:37PM	1 Healthcare Stock Worth Investigating and 2 That Underwhelm (StockStory)
Jan-13-26 09:00AM	Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening (Business Wire)
Jan-10-26 03:00PM	More Bonds Are Teetering on the Brink of Junk: Credit Weekly (Bloomberg)
Jan-09-26 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jan-08-26 11:51AM	Halper Sadeh LLC Encourages HOLX, VTYX, QRVO, TEX Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
11:40AM	HOLX vs. SONVY: Which Stock Should Value Investors Buy Now? (Zacks)
06:44AM	What You Need To Know Ahead of Hologic's Earnings Release (Barchart)
Jan-07-26 11:40AM	HOLX or SONVY: Which Is the Better Value Stock Right Now? (Zacks)
Jan-06-26 11:40AM	HOLX vs. SONVY: Which Stock Is the Better Value Option? (Zacks)
08:17AM	Hologic's Breast Health Unit Stays In Focus in 2026: What Lies Ahead? (Zacks)
Jan-05-26 07:17AM	Hologic Trading Near 52-Week High: How Should You Play the Stock? (Zacks)
Dec-31-25 08:55AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
07:25AM	Smart Oncology: 5 Stocks Chasing the $317B Prize (PR Newswire)
Dec-26-25 07:53AM	Hologic's GYN Surgical Segment Looks Poised for Long-Term Growth (Zacks)
Dec-24-25 10:31PM	Spotting Winners: Hologic (NASDAQ:HOLX) And Medical Devices & Supplies - Imaging, Diagnostics Stocks In Q3 (StockStory)
Dec-23-25 06:56PM	Halper Sadeh LLC Encourages SNCR, HOLX, FRGE Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
09:00AM	Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock (Zacks)
Dec-22-25 07:58AM	HOLX vs. LH: Which MedTech Stock Is the Stronger Investment Now? (Zacks)
Dec-18-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
Dec-17-25 12:01PM	HOLX's Genius AI Mammography Flags Missed Breast Cancer Cases (Zacks)
09:50AM	Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term (Zacks)
08:26AM	Hologic's Genius AI Detection Shows Value by Spotting Missed Cancers (Zacks)
Dec-12-25 09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
07:34AM	What Is Driving Hologic's Strength in the US Diagnostics Market? (Zacks)
04:04AM	Is Hologic Stock Outperforming the Nasdaq? (Barchart)
Dec-11-25 08:54PM	Halper Sadeh LLC Encourages DHIL, SNCR, FRGE, HOLX Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
Dec-08-25 09:19AM	HOLX Stock Up 16% in 6 Months: Is it Still a Hold Heading Into 2026? (Zacks)
Dec-07-25 11:37PM	1 Mooning Stock on Our Watchlist and 2 Facing Headwinds (StockStory)
Dec-06-25 01:25PM	US Loses Financing Edge as Asia Borrows in Euros: Credit Weekly (Bloomberg)
Dec-04-25 10:23AM	Hologic's BCI Test Shows Growing Impact in Endocrine Therapy Decisions (Zacks)
Dec-03-25 12:45PM	Cooper Companies to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
11:30AM	Why Is Hologic (HOLX) Up 1% Since Last Earnings Report? (Zacks)
Dec-02-25 08:10AM	New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration (Business Wire)
Dec-01-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Nov-27-25 08:23AM	HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet? (Zacks)
Nov-26-25 09:40AM	Here's Why Hologic (HOLX) is a Strong Value Stock (Zacks)
08:18AM	New Clinical Evidence Bolsters Hologic's Breast Cancer Technologies (Zacks)
Nov-25-25 08:08AM	New Clinical Evidence on Hologics AI-Powered Mammography Solutions Will Be Unveiled at RSNA (Business Wire)
Nov-21-25 09:10AM	Here Are Fridays Top Wall Street Analysts Research Calls: Advanced Micro Devices, Block, Broadcom, Exact Sciences, Hologic, Palo Alto Networks and More (24/7 Wall St.)
07:13AM	Hologic's GYN Surgical Delivers a Standout Quarter: What's Behind It? (Zacks)
Nov-20-25 09:31AM	US healthcare group Abbott bets on cancer screening technology in $23bn deal (Financial Times)
Nov-19-25 11:02PM	3 Reasons HOLX is Risky and 1 Stock to Buy Instead (StockStory)
Nov-18-25 09:29AM	Should You Continue to Hold Hologic Stock Post Q4 Earnings? (Zacks)
09:00AM	Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know (Zacks)
Nov-14-25 04:01PM	VolitionRX Ltd (VNRX) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Revenue ... (GuruFocus.com)
03:19PM	Halper Sadeh LLC Encourages CDTX, MRSN, HOLX Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
Nov-13-25 08:49AM	Hologic Expands European Reach of Genius Digital Diagnostics System (Zacks)
Nov-12-25 09:50AM	Here's Why Hologic (HOLX) is a Strong Momentum Stock (Zacks)
08:11AM	Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking (Business Wire)
Nov-11-25 11:41AM	The transatlantic medtech investment gap: why does it exist and can it be plugged? (Medical Device Network)
Nov-10-25 09:40AM	Why Hologic (HOLX) is a Top Value Stock for the Long-Term (Zacks)
Nov-07-25 04:36PM	Halper Sadeh LLC Encourages IMXI, CMA, HOLX Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
09:00AM	Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock (Zacks)
07:37AM	Hologic's Breast Health Rebounds, Takes Spotlight in Buyout Deal (Zacks)
Nov-04-25 08:07AM	HOLX Stock Up on Q4 Earnings & Revenue Beat, Operating Margin Expands (Zacks)
Nov-03-25 06:45PM	Analyst Report: Hologic, Inc. (Morningstar Research)
05:30PM	Hologic (HOLX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:15PM	Hologic (HOLX) Q4 Earnings and Revenues Beat Estimates (Zacks)
04:28PM	Hologic (NASDAQ:HOLX) Exceeds Q3 Expectations (StockStory)
04:22PM	Hologic: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025 (Business Wire)
Nov-01-25 11:06PM	Hologic (HOLX) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Oct-30-25 12:25PM	Halper Sadeh LLC Encourages HOLX, FITB, HSII Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
09:06AM	HOLX vs. ABT: Which Medical Technology Stock Is the Better Investment? (Zacks)
Oct-29-25 09:15AM	Gear Up for Hologic (HOLX) Q4 Earnings: Wall Street Estimates for Key Metrics (Zacks)
Oct-28-25 10:00AM	Waters (WAT) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focus on women's health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stamoulis Christiana	Director	Oct 20 '25	Option Exercise	36.04	7,402	266,768	54,738	Oct 22 04:17 PM
Stamoulis Christiana	Director	Oct 20 '25	Sale	73.07	7,402	540,864	47,336	Oct 22 04:17 PM
Stamoulis Christiana	Director	Oct 20 '25	Proposed Sale	73.07	7,402	540,864		Oct 20 10:12 AM
MACMILLAN STEPHEN P	Chairman, President and CEO	Sep 22 '25	Option Exercise	39.96	138,358	5,528,786	1,372,982	Sep 23 04:10 PM
MACMILLAN STEPHEN P	Chairman, President and CEO	Sep 22 '25	Sale	66.97	138,358	9,266,118	1,234,624	Sep 23 04:10 PM
MACMILLAN STEPHEN P	Officer	Sep 22 '25	Proposed Sale	66.98	138,358	9,266,548		Sep 22 04:25 PM
Madaus Martin D	Director	May 07 '25	Buy	55.24	5,445	300,760	5,445	May 09 04:39 PM

HCWB

HCW Biologics Inc

HOLX

Hologic, Inc

Upgrade your FINVIZ experience